4//SEC Filing
NEWELL WILLIAM J 4
Accession 0001415889-25-006690
CIK 0001382101other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:32 PM ET
Size
13.6 KB
Accession
0001415889-25-006690
Insider Transaction Report
Form 4
NEWELL WILLIAM J
DirectorCEO
Transactions
- Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-01−41,750→ 125,250 totalExp: 2028-03-01→ Common Stock (41,750 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-01−23,750→ 47,500 totalExp: 2027-03-01→ Common Stock (23,750 underlying) - Exercise/Conversion
Common Stock
2025-03-01+23,750→ 243,953 total - Exercise/Conversion
Common Stock
2025-03-01+41,750→ 285,703 total - Tax Payment
Common Stock
2025-03-01$1.59/sh−25,203$40,073→ 260,500 total
Holdings
- 116,525(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019.
- [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F4]The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
- [F5]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001309660
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:32 PM ET
- Size
- 13.6 KB